Xspray

XSPRAY.ST

Tags: SE Healthcare Biotechnology

Xspray Pharma AB (publ) Price (XSPRAY.ST)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

26,593,910

(25.0734)%

Market Cap of Xspray (XSPRAY.ST)

Market cap:

As of , XSPRAY.ST has a market cap of . This makes XSPRAY.ST the 173th most valuable company in the SE by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include HyNap-Nilo for the treatment of chronic myeloid leukemia; HyNap-Sora for the treatment of renal cancer and liver cancer, as well as several forms of thyroid cancer; and HyNap-Dasa for the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) w... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $28.3-91.7
Market Cap 930.81M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Dr. Per Andersson Ph.D.
IPO Date: September, 28, 2017
Country: SE
Currency: SEK
Headquaters: No Data
Employees: 26

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: